The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight ...

Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

International Community Health Services (ICHS) has launched Together We Rise, a wellness podcast with useful information ...

Q: What are your thoughts on the Ozempic, Wegovy and similar drugs when used exclusively for weight loss/management? (Versus diabetes.) A: People living with obesity have historically been told to eat ...